Alzheimer's and Microbes

Abstract

For twenty-five years, professor Ruth Itzhaki’s research on microbes as a possible cause of Alzheimer’s diseases was dismissed and ridiculed. The idea that there could be a potential bridge between two starkly different fields–virology and neurodegeneration–seemed absurd at the time. Now, Itzhaki’s work is the backbone of an ongoing, cutting-edge trial on antiviral treatments for Alzheimer’s at Columbia University.